HCA Healthcare, Inc. (HCA) is set to announce its fiscal Q3 2025 earnings, with a market cap of $102.4 billion. Analysts predict a profit of $5.64 per share, reflecting an 11.7% increase. Expectations for fiscal 2025 show a profit of $26.30 per share, a 19.8% rise from the previous year.

Despite lagging behind the S&P 500 Index, HCA has outperformed the Health Care Select Sector SPDR Fund. Shares fell 2.1% after Q2 results were reported, with revenue up 6.4% and adjusted EPS surpassing estimates. Analysts hold a “Moderate Buy” rating, with a Street-high price target of $449.

Wall Street analysts show optimism for HCA Healthcare, Inc.’s stock with a “Moderate Buy” rating overall. Analysts expect a promising trajectory for the company, projecting growth in earnings per share in fiscal 2025 and 2026. Despite some volatility, the company’s stock is trading above its mean price target, indicating a potential upside.

Read more at Yahoo Finance: What to Expect From HCA Healthcare’s Q3 2025 Earnings Report